The canine pyoderma treatment market is projected to grow from USD 2.1 billion in 2026 to USD 3.7 billion by 2036, at a CAGR of 5.8%. Systemic antibiotics will dominate with a 38.0% market share, while superficial pyoderma will lead the application segment with a 48.0% share.